[ Price : $8.95]
FDA releases an FDA-483 with three observations from an inspection at the Atlas Pharmaceuticals outsourcing facility in Phoenix, A...[ Price : $8.95]
FDA clears a Flume Catheter Co. 510(k) for its Flume urinary balloon catheter.[ Price : $8.95]
FDA acting commissioner Janet Woodcock testifies before Congress about an agency priority to increase the availability of over-the...[ Price : $8.95]
FDA testimony at a Senate hearing on Covid-19 discusses the unprecedented number of new product submissions to fight the disease a...[ Price : $8.95]
A Reuters series documents the role diabetes drug marketing techniques played in a significant increase in cases of hypoglycemia a...[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 4/2/2020.[ Price : $8.95]
FDA posts a draft guidance entitled Dry Eye: Developing Drugs for Treatment that is intended to provide recommendations to sponsor...[ Price : $8.95]
FDA approves Myovant Sciences Orgovyx (relugolix) for treating adult patients with advanced prostate cancer.